MedPage Today on MSN
First-in-Class Drug Approved for IgA Nephropathy
It has not been established whether atacicept slows kidney function decline long-term, how ...
Iga Swiatek’s Wimbledon defense is already over. Swiatek, the No. 3 seed in the women’s draw, was shocked in the third round ...
Data from the first stage of a phase 3 study show significant reductions in proteinuria among patients treated with telitacicept.
Although known for her stoicism, Świątek’s battle back to World No. 1 can sometimes feel like a “Highway to Hell.” ...
The FDA granted accelerated approval to atacicept-vymj for proteinuria reduction in adults with primary immunoglobulin A ...
ORIGIN 3 randomized 431 biopsy‑confirmed IgAN patients 1:1; atacicept 150 mg weekly SC produced the largest placebo‑adjusted UPCR reduction reported at week 36. Accelerated approval hinged on ...
In January 2025, PowerSchool’s student information system was hacked, exposing the names, addresses and other information of more than tens of millions of schoolchildren and their parents. “Private ...
As the most abundant class of antibodies found in the intestinal lumen of humans and in most other mammals, secretory IgA (SIgA) has long been recognized as a first line of defense in protecting the ...
IgA nephropathy is a relatively newly recognized disease, first described by Berger and Hinglais in 1968. 1 It is now generally known to be the most common form of primary glomerulonephritis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results